Jake Nunn

CFA Society of San Francisco provides educational services. It offers a multi-review course which provides structured, classroom-based approach to preparing for the examination. The firm focuses on the assigned materials in the study guides from CFA Institute, with an emphasis on the Learning Outcome Statements (LOS). The company was founded in 1929 and is headquartered in San Francisco, CA.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX.

Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN.

Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA.

Trivascular Technologies, Inc. operates as a medical device company developing and commercializing technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company was founded on July 11, 2007 and is headquartered in Santa Rosa, CA.

TriVascular, Inc. develops and manufactures medical devices. It provides devices and procedures for treating abdominal aortic aneurysms and endovascular grafts. The company was founded by Michael V. Chobotov, Robert G. Whirley, and Joseph W. Humphrey in 1998 and is headquartered in Irvine, CA.

Oventus Medical Ltd. develops oral appliances for the treatment of obstructive sleep disordered and snoring. It offers an oral device under the O2Vent brand. The O2Vent unique design directs the air flow through to the back of the throat, alleviating multiple sites of obstruction including the nose, soft palate and tongue The company was founded by Christopher Patrick Hart in 2012 and is headquartered in Indooroopilly, Australia.

Qool Therapeutics, Inc. develops non-invasive temperature management therapies to induce therapeutic hypothermia. The company was founded by Amir Belson in 2005 and is headquartered in Menlo Park, CA.

Franklin Templeton Investments Corp. (FTI) is a SEC-registered investment advisor and mutual fund manager headquartered in Toronto, Canada. The firm was founded in 2000 and they are a subsidiary of Templeton International, Inc. Their ultimate parent is Franklin Resources, Inc. (NYSE: BEN), a global investment management company also known as Franklin Templeton Investments. FTI provides investment advisory and portfolio management services with clients in jurisdictions worldwide, which include registered open-end and closed-end funds and unregistered funds, as well as separate accounts for institutional and high net-worth clients.

Humanetics Corp. engages in development and commercialization of bioactive compounds. Its products include radiation modulators, mechanism of action, safety and toxicology, and pharmacokinetics. It focuses on oncology, medical imaging, and medical countermeasures. The company was founded by Ronald J. Zenk in 1988 and is headquartered in Edina, MN.

SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California.